The Medical Technologies Evaluation Programme selects technologies for evaluation.

For a full description of the process see the:

Timeline

Week 0

Scope prepared

The scope defines the:

  • disease(s)

  • patients and technology covered by the assessment

  • questions the guidance aims to answer.

We prepare the draft scope using the:


Week 4

Draft scope circulated for comment

We invite registered stakeholders to comment on the scope.

Register as a stakeholder

Once the scope is finalised, we publish it on our website.


Week 6

Company submission

The company prepares and submits their evidence based on the final scope. The evidence aims to respond to the questions raised in the scope. They have 6 weeks to provide the information.

Example of an evidence submission document (Word)


Week 8

Assessment report

An independent external assessment centre reviews and critiques the evidence. They then prepare an assessment report.

The assessment centres were chosen through a public tender. They have knowledge of and expertise in evaluating medical technologies.

This takes approximately 6 weeks.


Week 18

Overview compiled

The overview highlights the key issues and uncertainties in the companies submission and assessment report. It is part of the information used by the committee when they agree the draft recommendations.


Week 21

Medical technologies advisory committee (MTAC) meeting

The medical technologies advisory committee (MTAC) is an independent advisory committee which meets monthly. The relevant meeting papers are sent to members 2 weeks prior to the meeting.

MTAC considers all the evidence presented and formulates draft recommendations. A consultation document is prepared after the meeting.

The meeting is open to members of the public.

Find out how to register to attend a meeting.


Week 24

Consultation on draft recommendations opens

MTAC makes its provisional recommendations in the consultation document.

Registered stakeholders have 4 weeks to comment.

We publish the document on our website. Health professionals and members of the public can also comment on it.

View current consultations.


Week 30

Final guidance written

The committee considers the comments received on the consultation document, then makes its final recommendations.


Week 33

Resolution

Once our Guidance Executive has approved the final guidance, it is open to resolution. This is a final quality assurance step before the guidance is published.

Anyone who commented on the consultation can request we make corrections if they believe:

  • there has been a breach of process

  • there are factual errors in the guidance.

Commentators have 3 weeks to submit their comments.

You can find out more about resolution in chapter 6 of the process guide.


Week 38

Guidance issued

If there are no resolution requests, the final guidance is published.

If we receive resolution requests, we suspend publishing the guidance while we investigate them.